Use of paclitaxel carried in lipid core nanoparticles in patients with late-stage solid cancers with bone metastases: lack of toxicity and therapeutic benefits (2022)
- Authors:
- USP affiliated authors: MARANHAO, RAUL CAVALCANTE - FCF ; VITAL, CAROLINA GRAZIANI - FCF
- Unidade: FCF
- DOI: 10.1016/j.jbo.2022.100431
- Subjects: NANOPARTÍCULAS; NEOPLASIAS ÓSSEAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Bone Oncology
- ISSN: 2212-1374
- Volume/Número/Paginação/Ano: v.34, p. 1-7, art. 100431
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
VITAL, Carolina Graziani et al. Use of paclitaxel carried in lipid core nanoparticles in patients with late-stage solid cancers with bone metastases: lack of toxicity and therapeutic benefits. Journal of Bone Oncology, v. 34, p. 1-7, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jbo.2022.100431. Acesso em: 01 fev. 2026. -
APA
Vital, C. G., Maranhão, R. C., Freitas, F. R., Eyll, B. M. V., & Graziani, S. R. (2022). Use of paclitaxel carried in lipid core nanoparticles in patients with late-stage solid cancers with bone metastases: lack of toxicity and therapeutic benefits. Journal of Bone Oncology, 34, 1-7. doi:10.1016/j.jbo.2022.100431 -
NLM
Vital CG, Maranhão RC, Freitas FR, Eyll BMV, Graziani SR. Use of paclitaxel carried in lipid core nanoparticles in patients with late-stage solid cancers with bone metastases: lack of toxicity and therapeutic benefits [Internet]. Journal of Bone Oncology. 2022 ;34 1-7.[citado 2026 fev. 01 ] Available from: https://doi.org/10.1016/j.jbo.2022.100431 -
Vancouver
Vital CG, Maranhão RC, Freitas FR, Eyll BMV, Graziani SR. Use of paclitaxel carried in lipid core nanoparticles in patients with late-stage solid cancers with bone metastases: lack of toxicity and therapeutic benefits [Internet]. Journal of Bone Oncology. 2022 ;34 1-7.[citado 2026 fev. 01 ] Available from: https://doi.org/10.1016/j.jbo.2022.100431 - Treatment of bone metastasis with the association of paclitaxel to lipid nanoparticles in patients with malignant solid tumors
- Uptake of lipid core nanoparticles by fragments of tissues collected during cerebral tumor excision surgeries: hypotheses for use in drug targeting therapy
- Avaliação preliminar do tratamento de pacientes portadoras de câncer de ovário avançado com nanopartícula lipídica associada ao quimioterápico paclitaxel
- Avaliação do tratamento quimioterápico paliativo com o esquema LDE- paclitaxel em pacientes portadores de metástases ósseas por neoplasia maligna
- Atividade das lipases hepática e lipoprotéica na síndrome dos ovários policísticos
- Deposition in the aorta of free and esterified cholesterol contained in a microemulsion that mimics the lipid composition of ldl in rats, rabbits and patients with coronary artery disease
- Alterations on the cholesterol uptake after treatment with diazepam in rats
- Lipidic nanoparticles in combined chemotherapy: in vivo inhibition of melanoma B16F10 growth
- The effects of resistance exercise on plasma kinetics of an artificial nanoemulsion that binds to low-density lipoprotein receptors
- Effects of simvastatin on the transfer of lipids to high density lipoprotein in coronary artery disease patients
Informações sobre o DOI: 10.1016/j.jbo.2022.100431 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3075878.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
